SK bioscience wins case two years after filing suit challenging global company´s patent monopo...

-Award established in 2021 to honor the legacy of the late Vice Chairman Park MahnHoon and promote v...

750,000 doses of influenza vaccine to be supplied to Southeast Asia and Latin America in the first h...

SKYVaricella®, supplied to Latin America since 2022 through PAHO, secures an additional three-year s...

SK bioscience’s first mRNA vaccine candidate enters Phase 1/2 clinical trials in Australia and New Z...

? SK-Sanofi launches RSV preventive antibody injection for all infants under 12 months.? RSV, a majo...

-Collaborated with key global health authorities, including IVI, the U.S. FDA, and the U.K. MHRA-The...

-Two companies signed a co-promotion and distribution agreement for Beyfortus® and Avaxim®, expandin...

-U.S. FDA has reviewed the Investigational New Drug (IND) amendment for the Phase 3 clinical studies...

-Both companies sign an expanded agreement to develop next-generation pneumococcal vaccines.-SK bios...

-SK bioscience’s first mRNA vaccine candidate is expected to enter clinical trials in Australia in F...

This approval paves the way for exports to the world´s fourth most populous country.SK bioscience ai...